Asset Allocation Fund REGN Holdings History
Asset Allocation Fund's Regeneron Pharmaceuticals Inc Holding Summary
As of 2025-03-31, AMERICAN FUNDS INSURANCE SERIES held - shares of Regeneron Pharmaceuticals Inc(REGN), totaling N/A. This investment constitutes 0% of their stock portfolio, and AMERICAN FUNDS INSURANCE SERIES now holds 0% of the outstanding Regeneron Pharmaceuticals Inc(REGN) stock.
The initial trade took place in 2020Q2. And since then Asset Allocation Fund has made 4 purchases of REGN, at an average price of $598.36, for a total of 241,175.00 shares. In addition, there have been 4 sales at an average price of $749.22 for 241,175.00 shares. Based on historical transaction data and REGN's current price of $567.74, Asset Allocation Fund's estimated gain on his REGN holdings is $36.38 Mil, reflecting a 25.21% gain to date.
Asset Allocation Fund REGN ($567.74) Holding Chart
Asset Allocation Fund REGN ($567.74) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
